BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 8, 2004
View Archived Issues
SuperGen Brings In $34M Via Private Sale Of Stock, Warrants
It seems SuperGen Inc. decided to change its course. Just weeks after disclosing plans to withdraw a proposed stock offering, the cancer drug development company raised $34 million through a stock-and-warrant sale. (BioWorld Today)
Read More
FDA Requesting Feedback On Impact Of Medicare Changes
Read More
Shamrock Structures Offering 3-D Protein Structure Services
Read More
Angiotech's Technology Approved In Boston Scientific's Coated Stent
Read More
Other News To Note
Read More
Appointments And Advancements
Read More